|
VAV2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.34300000015553E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.10499999945213E-07 |
| Normal-vs-Stage2 |
9.923500E-03 |
| Normal-vs-Stage3 |
6.675500E-03 |
| Normal-vs-Stage4 |
2.169900E-04 |
| Stage1-vs-Stage2 |
7.452600E-01 |
| Stage1-vs-Stage3 |
8.691800E-01 |
| Stage1-vs-Stage4 |
5.277400E-01 |
| Stage2-vs-Stage3 |
7.173200E-01 |
| Stage2-vs-Stage4 |
3.852400E-01 |
| Stage3-vs-Stage4 |
6.770600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.92880000005058E-06 |
| Normal-vs-AfricanAmerican |
1.58937999999997E-05 |
| Normal-vs-Asian |
1.64532999999967E-05 |
| Caucasian-vs-AfricanAmerican |
5.856200E-01 |
| Caucasian-vs-Asian |
1.266000E-01 |
| AfricanAmerican-vs-Asian |
1.123770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.95750000045558E-08 |
| Normal-vs-Female |
2.059700E-02 |
| Male-vs-Female |
6.802100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.136700E-03 |
| Normal-vs-Extreme_Weight |
9.63879998039374E-09 |
| Normal-vs-Obese |
2.036300E-02 |
| Normal-vs-Extreme_Obese |
9.029800E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.433000E-01 |
| Normal_Weight-vs-Obese |
3.868200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.683600E-01 |
| Extreme_Weight-vs-Obese |
3.192200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.784000E-01 |
| Obese-vs-Extreme_Obese |
8.156800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.163600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.187590E-04 |
| Normal-vs-Age(61-80Yrs) |
1.84999999985891E-07 |
| Normal-vs-Age(81-100Yrs) |
1.140440E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.903200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.043000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.345200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.549410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.584800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.190200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.38399999999517E-06 |
| Normal-VS-Type2 PRCC |
6.23160000268186E-08 |
| Normal-VS-KIRP CIMP |
7.575200E-01 |
| Normal-VS-Unclassified PRCC |
2.116400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.932000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.472810E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.562200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.876800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.100450E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.338230E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.86829999973648E-07 |
| Normal-vs-N1 |
1.247800E-01 |
| Normal-vs-N2 |
1.718360E-02 |
| N0-vs-N1 |
2.726600E-01 |
| N0-vs-N2 |
8.181200E-01 |
| N1-vs-N2 |
7.361000E-01 |
|
|
